Cn1cnc2c(=O)oc3ccc(S(=O)(=O)N4CCN(c5cccc(Cl)c5)CC4)cc3c21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?